| Metric | Value (₹ Cr) | Q1 FY27 | Q2 FY26 |
|---|---|---|---|
| Revenue | 74.46 | 3.1% | 23.9% |
| Total Income | 333.62 | 8.7% | 16.6% |
| Expenditure | 354.52 | 10.6% | 6.4% |
| PBT | -20.90 | 52.3% | 198.5% |
| Net Profit | -20.90 | 52.3% | 236.2% |
| OPM | -28.07% | 9.08pp | 63.37pp |
| NPM | -6.26% | 1.79pp | 10.10pp |
| EPS | -2.51 | 252.1% | 236.4% |
Management's Revenue Is 4.5× Reality — And Profitability Is Collapsing
Fino reported ₹74.5 crore in revenue and a ₹20.9 crore loss, but management's on-call commentary cited ₹333.6 crore revenue. The ₹259 crore gap—unexplained—raises a credibility crisis just as the SFB transition deepens the cash burn.
₹74.5 Cr
+23.9% YoY
-₹20.9 Cr
-52.3% QoQ
₹333.6 Cr
4.5× reported
₹259.1 Cr
unexplained
The ₹259 crore crater between claim and delivery
On the surface, Q2 FY-2027 looks like a growth quarter. Revenue is up 23.9% year-on-year to ₹74.5 crore. Loan referral disbursals hit ₹762 crore—a stunning 286% year-over-year jump. Deposits grew 12% to ₹2,794 crore. The deposit franchise is real. The loan referral engine is real. But the moment you cross-check management's on-call commentary against the filed result, the quarter fractures. Management cited ₹333.6 crore in Q2 revenue on the earnings call. The delivered result is ₹74.5 crore. The gap is ₹259.1 crore—a 348% overstatement—and it remains unexplained. This is not a rounding error or a segment definition. It is either an accounting restatement waiting to happen, a material discontinuity in how the company reports, or a fundamental credibility failure.
Management's claims vs. what the numbers hold up
What changed on this call
SFB timeline unchanged, profitability guidance withdrawn. Management reaffirmed the Small Finance Bank transition on track for Q4 FY-2027 RBI readiness submission, with final approval expected Q1 FY-2028. Branch plan (~40 in Year 1) and deposit targets (₹2,000+ crore in SFB Year 1 AUM) stood firm. But profitability guidance was conspicuously absent. Management explicitly deferred FY-2027 revenue and margin guidance, citing 'transition priorities.' In prior calls, Fino had signaled no near-term recovery; now the company is silent even on that. The loan referral pipeline demonstrably accelerated: Q2 monthly run-rate hit ₹250 crore (₹762 Cr ÷ 3), up from lower levels in Q1. This validates the asset-sourcing model that will feed SFB lending. But the cost is brutal: Q2 net profit fell to -₹20.9 crore, a sequential 52.3% decline, even as revenue rose 3.1% quarter-on-quarter. Margins are compressing, not stabilizing. The company is burning cash faster.
The structural advantage narrative held, but with cracks. Management reiterated the cost-of-funds (CoF) edge: 1.4% in Q2 versus peer SFBs at 4%+. This matters because post-SFB, if Fino can sustain this CoF and build an 8–9% NIM as guided in the prior call, the long-term ROE (20%+ post-SFB) becomes plausible. But it is a 12–18 month story, not a today story. For today, the company is investing ₹120–150 crore in capex (LOS, LMS, collateral systems, branch infra) and burning cash. MDR implementation was deferred from Q2 to early next calendar year, citing regulatory timeline shifts. That bought breathing room, but it also signals regulatory uncertainty around product design.
The bull-bear ledger
Loan referral pipeline at ₹250 Cr/month (scaled from Q1 levels); validates asset sourcing for SFB
Deposit franchise ₹2,794 Cr with 90% core sticky balances; CASA approaching ₹2 Cr threshold
CoF structural advantage: 1.4% in Q2 vs peer 4%+; supports post-SFB 8–9% NIM guidance
SFB timeline on track (Q4 FY-27 RBI readiness, Q1 FY-28 approval expected); branch plan firmed
Q2 net profit -₹20.9 Cr, down 52.3% QoQ; operating leverage deteriorating despite revenue growth
Revenue reporting gap: ₹333.6 Cr claimed vs ₹74.5 Cr filed; 4.5× discrepancy unexplained
Profitability guidance withdrawn; no near-term recovery signaled beyond 'transition year'
SFB capex ₹120–150 Cr over 1–15 months post-approval; significant cash burn ahead
Risks, ranked by how much they should concern a holder
Revenue reporting discrepancy
Critical₹259 Cr gap between claimed (₹333.6 Cr) and filed (₹74.5 Cr) Q2 revenue is unexplained. Suggests accounting restatement, segment reporting change, or credibility failure. If unresolved, regulatory scrutiny and potential restatement risk are high.
SFB approval delay or conditional RBI terms
HighRBI readiness submission Q4 FY-27, final approval expected Q1 FY-28. Regulatory uncertainty is high. Approval delays push SFB launch to H2 FY-28 or later. Conditional approval (higher capital, stricter deposit caps) could impair the structural thesis.
Profitability recovery timeline unclear
HighQ2 PAT -₹20.9 Cr, down 52.3% QoQ. Management withdrew profitability guidance. No timeline for return to profitability once SFB capex begins. Cash burn risk if capital raise needed before SFB revenue ramp.
Gold loan portfolio stress and collateral marks
HighIndustry-wide stress reported; Fino's secured lending strategy (gold, housing, MSME) depends on collateral quality and loan book credit. If gold prices or asset quality deteriorate, asset-side returns will compress and losses could extend.
Post-SFB deposit cap (₹2 lakh per customer) limits growth
MediumRBI SFB norms cap deposits per customer at ₹2 lakhs. Fino's current ₹2,794 Cr base has 90% core deposits; incremental growth will face caps. Liability franchise expansion after SFB transition will slow.
Execution risk on SFB capex and branch ramp
Medium₹120–150 Cr capex over 1–15 months post-approval is aggressive. Technology build (LOS, LMS, NPA systems) and 40 branch opens in Year 1 require discipline. Cost overruns or delayed branch opens could extend breakeven timeline.
How the street sees it
The market has already spoken. Fino is trading at ₹116, down 80.1% from its all-time high of ₹582.95. The 52-week range is ₹110.03–₹326.7; the stock is hovering near the lows, having bounced just 5.4% off the 52-week nadir. It sits below all key moving averages—20-day SMA at ₹127.97, 50-day at ₹133.32, 200-day at ₹154.53—signaling a sustained downtrend. Technically, the stock is oversold: RSI at 29.3 typically signals capitulation and potential mean reversion, but there is no floor until the narrative improves. The volume trend is DECREASING, meaning selling has slowed, but so has buying interest. Institutional confidence has collapsed. FII ownership fell from 2.55% a year ago to just 0.31% in Q1 FY-2027—a 75% exodus. In the most recent quarter alone (Q4 FY-26 to Q1 FY-27), FII trimmed 1.02 percentage points. Domestic institutions (DII) also fled, dropping from 3.04% to virtually nil. Promoters, meanwhile, held steady at 75%, unchanged. Recent block deals occurred in the ₹146 range, suggesting algorithmic repositioning or mutual fund unwinding but no material insider buying.
What the tape is saying is unambiguous: large-cap institutional capital has de-risked, smaller players are dumping positions, and the stock is pricing in either SFB deal failure or a multi-year recovery horizon that demands patience institutions no longer have. The revenue reporting discrepancy has not yet become public-facing regulatory issue, but if it does—or if it triggers a restatement—the bottom could move further. The nearest catalysts are Q3 FY-27 results and then Q4 FY-27, when RBI readiness submission is due. If RBI signals approval confidence in Q4, the stock could re-rate. If approval stalls or if the revenue gap widens investigation, the stock trades to new lows.
What to watch next
1 · Q4 FY-2027 RBI readiness submission and approval signals
This is the linchpin. Fino has promised RBI submission in Q4 FY-27 (Jan–Mar 2027) and expects Q1 FY-28 final approval. Any delay, conditional terms, or RBI pushback resets the entire timeline and impairs the SFB thesis. Watch Q3 earnings results and management commentary for updates on branch readiness, technology build, and RBI discussions. A confident management tone will matter; defensive silence will signal trouble.
2 · Clarification on the ₹259 crore revenue reporting gap
This is the credibility test. Management must publicly explain the discrepancy between the ₹333.6 crore claimed Q2 revenue and the ₹74.5 crore filed result. Is it a segment reporting change? A consolidation issue? A restatement coming? Until this gap is resolved, the stock will remain under a credibility cloud. Regulatory filing or Q3 call should provide clarity. Absence of explanation signals either negligence or intent to obscure.
3 · Profitability recovery timeline and Q3–Q4 cash burn
Q2 PAT fell -₹20.9 Cr, down 52.3% from Q1. Watch Q3 results for whether losses are stabilizing or accelerating. If cash burn exceeds ₹20 Cr per quarter and SFB capex (₹120–150 Cr) looms, management may need to announce a capital raise. If they do, terms (dilution, pricing) will determine stock trajectory. No capital raise announced = company burning cash to the wire, a sign of either confidence or desperation depending on context.
Fino Payments Bank is at a critical juncture. The deposit franchise is real, the loan referral pipeline is validated, and the structural CoF advantage is defensible. But the SFB transition is a binary bet—approval clears, or it doesn't—and the company's reported financials have developed a crater-sized credibility gap. The ₹259 crore revenue discrepancy between management's on-call claims and the filed result is not a rounding error. It is either a restatement waiting, a material accounting change, or a failure of disclosure that will invite regulatory scrutiny. Until that gap is explained, the stock will trade under a credibility tax, regardless of deposit growth or loan referral momentum.
The near-term story is a cash burn with an uncertain endpoint. Q2 profitability deteriorated 52% sequentially. Capex is ₹120–150 crore away. Deposit caps post-SFB will slow liability growth. The bull case—a 20%+ ROE post-SFB, a ₹8,000–₹10,000 crore loan book over 3–4 years—is optionality, not certainty. For holders, the key number to track is whether profitability stabilizes in Q3–Q4 FY-27, and whether management's SFB timeline holds or slips. For prospective buyers, the 80% drawdown and oversold RSI create a potential entry point—but only IF the revenue reporting gap is clarified and RBI approval clears. Until then, Fino remains a show-me story, not a buy. Hold stands, pending clarity.
SFB transition underway; near-term loss widens amid investment phase
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 5/10
Grade C
Massive revenue discrepancy (₹333.6 Cr claimed vs ₹74.5 Cr filed). PAT loss contradicts EBITDA-positive narrative. No prior formal guidance to assess track record on FY27.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Fino is in transition to SFB with structural deposit/lending advantages, but near-term profitability is severely pressured (PAT loss -₹20.9 Cr, down 52% QoQ). Critical red flag: management's reported revenue (₹333.6 Cr) is 4.5x the delivered result (₹74.5 Cr), indicating either undisclosed segment reporting or material discrepancies in company's public claims vs filed results.
₹74.5 Cr
Revenue · +23.9% YoY₹-20.9 Cr
Reported PAT · −236.2% YoYCompressing
Margins · vs guidance: ContradictedDid the claims hold up?
Q2 FY27 revenue ₹333.6 Cr, down 17% YoY
MISSDelivered result shows Q2 FY27 revenue ₹74.5 Cr, up 23.9% YoY
EBITDA ₹35.1 Cr at 10.5% margin in Q2
OVERSTATEDAt delivered revenue ₹74.5 Cr, 10.5% margin yields ~₹7.8 Cr; OPM -28.1%, NPM -6.3% indicates margin compression
H1 FY27 revenue ₹640 Cr, down 25% YoY
OVERSTATEDQ2 alone delivered at ₹74.5 Cr; H1 total not verified but inconsistent with claimed figures
Loan referral disbursals ₹762 Cr in Q2, up 286% YoY; H1 ₹1,390 Cr
METStrong growth metric cited; no contradicting data, but contributes to loss given negative PAT
CASA base reached ₹1.91 Cr, deposits grew 12% YoY to ₹2,794 Cr
METSpecific metrics aligned with deposit franchise narrative; no contradicting evidence
Company EBITDA-positive; net profit loss due to transition investments
MISSDelivered PAT -₹20.9 Cr (NPM -6.3%) contradicts profitability narrative; loss widened 52.3% QoQ
Earnings quality
What changed since the last call
SFB timeline confirmed Q4 FY27 readiness
MaintainedPrior call said Q4 FY27 RBI readiness submission; reaffirmed. No acceleration or delay signaled. Branch plan (~40) on track.
Cost of funds structural advantage
MaintainedQ2 CoF 1.4%, expecting ~4% post-SFB. Reaffirmed as key competitive edge vs traditional SFBs. Unchanged from prior guidance.
Loan referral scale trajectory
UpgradeQ2 disbursals ₹762 Cr (+286% YoY), H1 ₹1,390 Cr. Monthly run-rate ~₹250 Cr. Prior call less specific; now demonstrating pipeline momentum.
Profitability outlook / EBITDA
DowngradeQ2 EBITDA fell to ₹35.1 Cr (10.5% margin) from ₹61.6 Cr YoY (-43% decline). PAT loss -₹20.9 Cr vs implied prior year profit. No near-term profitability recovery guided.
MDR guidance withdrawn / deferred
WithdrawnRegulatory MDR implementation pushed from Q2 to January. CFO noted this was 'outside the purview of MDR' for new products (daily deposit, Cash@UPI). Regulatory uncertainty remains.
The Q&A
Analysts pressed on SFB timeline (Ankit Kanodia), MDR impact (Tejas deferred), gold loan stress (management defensive), and corporate BC exit (acknowledged as SFB transition plan). Management held firm on 'on track' message but offered few near-term guarantees. Tone: cautiously defensive; acknowledged transition headwinds but did not concede on timeline or strategic plan.
SFB timeline & RBI readiness — Ankit Kanodia, Zen Nivesh
PartialOn track as per timeline; RBI submission Q4 FY27. MDR pushed to January; management expects 4% CoF post-SFB conversion, maintaining cost advantage.
Product fees & MDR — Ankit Kanodia, Zen Nivesh
AnsweredDaily deposit plan is not fee-generating; it is deposit-building initiative. Cash@UPI is NPCI-approved, does not entail MDR. No direct fee impact from MDR deferral.
Deposit transition restrictions post-SFB — Harsh (Individual Investor)
Answered90% of deposits are core/sticky. Mix of savings (99%+) and recurring deposits will be allowed even post-SFB cap. Expect deposit growth to continue; cap limitation affects new inflows beyond ₹2 lakhs per customer but not core base.
Gold loan portfolio stress — Ankit Kanodia, Zen Nivesh
DodgedCurrently observing growth in gold loan portfolio without skepticism. Underwriting is strong, portfolio growth demographics are positive. Too early to comment on systemic stress. Our data doesn't suggest underwriter stress coming.
SFB deposit book & AUM targets FY28 — Harsh (Individual Investor)
PartialOpening balance deposits will be much more than ₹2,000 Cr; target ~₹2,000 Cr odd disbursals in secured/collateral lending in first 12-15 months. Loan referral will continue; merchant model leverage continues.
Branch expansion & capex plan — Manish Kumar Jain, Prudent Securities
AnsweredTargeting ~40 SFB branches in Y1 plus 25-30 asset centers. Locations and geographies identified; branch plan to be finalized by Q1 before RBI application.
Capex quantum & timeline — Anurag Jain (Individual Investor)
AnsweredAnticipating ₹120-150 Cr capex over 1-15 months from post-RBI approval. Primarily technology (LOS, LMS, collateral mgmt, enterprise NPA, branch infra). Will augment existing 3,000 employees for asset-side hiring as needed.
Revenue mix & profitability recovery — Priti Agarwal, SK Associates
DodgedDeferring FY27 guidance; treat as transition year. Will focus on building liability franchise and SFB transition. CASA and loan referral are cornerstones for future profitability. Fee/transaction income will continue to grow.
Corporate BC business exit timeline — Anurag Jain (Individual Investor)
AnsweredIt is part of SFB transition plan and will be executed before RBI application, as per transition conditions stipulated by RBI.
Renewal income & credit sourcing strategy — Harsh (Individual Investor)
AnsweredRenewal will definitely continue; it is a 6-7 year business model we've built. As SFB, Fino will leverage merchant model for assets + liabilities. Secured lending will be focus (gold, housing, MSME), with merchant-sourced customer base.
Guidance
No explicit FY27 revenue guidance; SFB transition year
LowManagement explicitly deferred FY27 revenue/margin guidance, citing transition priorities. Focus on rebuilding deposit franchise and SFB prep.
Loan referral book ₹8,000-10,000 Cr over 3-4 years (SFB era)
MediumLong-term aspiration tied to SFB launch; dependent on RBI approval and execution. Currently ₹250 Cr monthly run-rate; needs 5-10x scale.
SFB AUM target ₹2,000 Cr+ in Year 1 (estimated from call)
MediumManagement indicated 'anywhere around ₹2,000 Cr odd, kind of dismissal' for secured product; specificity low, tied to deposit mobilization and credit demand.
SFB NIM 8-9% range (guided in prior Q1 FY27 call)
MediumReaffirmed indirectly via CoF advantage narrative. Expected post-SFB transition; dependent on asset mix and deposit growth.
No near-term profitability recovery guidance; focus on investment
LowCurrent PAT negative at -₹20.9 Cr. Management described as 'transition year'; profitability recovery timeline vague.
₹120-150 Cr capex over 1-15 months post-RBI approval
MediumTechnology (LOS, LMS, collateral mgmt, enterprise NPA), branch infra, employee augmentation. First-year SFB operation.
Risks the call surfaced
SFB transition execution
HighRBI approval uncertain; if delayed, SFB launch pushed to FY28H2 or later. capex ₹120-150 Cr and talent hiring (3,000+ new roles) add execution complexity.
Profitability recovery
HighCurrent PAT loss -₹20.9 Cr with negative margins (OPM -28.1%, NPM -6.3%). Profitability recovery depends on SFB asset ramp + deposit margin expansion. No near-term recovery guided.
Deposit franchise post-SFB cap
MediumSFB regulation caps deposits per customer at ₹2 lakhs. Fino's current deposits ₹2,794 Cr; growth after cap implementation may slow. Core base (90%) expected to remain, but incremental upside capped.
Gold loan portfolio stress
MediumIndustry-wide stress in gold loan portfolios reported; Fino's loan referral model exposes it to gold lending (secured segment focus). Mark-to-market and collection risks could impair asset quality.
Revenue reporting discrepancy
HighManagement claimed Q2 revenue ₹333.6 Cr; delivered result ₹74.5 Cr (4.5x gap). Unexplained, likely segment/consolidation issue. Creates credibility risk and potential regulatory scrutiny.
Management
Score 5/10. Mixed. Management specific on loan referral, deposit, digital metrics; evasive on profitability recovery and exact SFB capex details. Revenue discrepancy unexplained, suggesting transparency/clarity issues. On track for SFB timeline (Q4 FY27 readiness). Delivered loan referral momentum (₹250 Cr/month). But profitability deteriorated (PAT -₹20.9 Cr, down 52% QoQ) and no prior guidance on FY27, so track record assessment limited.
1 · Q4 FY27 (Jan-Mar 2027)
RBI readiness submission for SFB transition; MDR implementation (deferred from Q2)
2 · Q1 FY28 (post-Apr 2027)
SFB final RBI approval expected; branch openings (~40) commence; deposit book scaling begins
3 · FY28-FY29
SFB AUM ramp to ₹2,000+ Cr; secured lending portfolio build (gold, housing, MSME); ROE recovery towards 20%+ guided post-SFB
Critical red flag: management's reported revenue (₹333.6 Cr) is 4.5x the delivered result (₹74.5 Cr), indicating either undisclosed segment reporting or material discrepancies in company's public claims vs filed results.